CTRI/2021/02/031467尚未招募1 期
comparision of 1:1 and 0.75:1 protamine to heparin for reversal of heparin in cardiac surgeries requiring cardio-pulmonary bypass: a randomised controlled study
Balabhadra Sai Priyanka0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients undergoing cardiac surgery requiring cardiopulmonary bypass
排除标准
- •known defects of haemostatic system
- •thrombocytopenia
- •surgeries requiring dhca
- •patients who didnt stop clopidogrel 5 days prior to surgery
研究者
相似试验
招募中
不适用
Observational study of heparin/protamine effects during extracorporeal circulatiocardiovascular surgery patients receiving extracorporeal circulationJPRN-UMIN000044929Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science30
招募中
不适用
Optimal dose of protamine for heparin reversal in open heart surgeryAdult patient underwent cardiopulmonary bypass surgerycardiopulmonary bypass,heparin,protamineTCTR20151118005Faculty of Medicine, Prince of Songkla University500
已完成
不适用
The effect of a high and low protamine-to-heparin dosing on perioperative hemostasis: a randomized clinical trialAntagonising heparincoagulation disorder1001108210007593NL-OMON36910Vrije Universiteit Medisch Centrum98
进行中（未招募）
不适用
The effect of different ratio's of inhibitors and activators of the coagulation on perioperative hemostasis during cardiac surgery.Patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypassMedDRA version: 17.1Level: LLTClassification code 10006894Term: CABGSystem Organ Class: 100000004865EUCTR2012-003359-12-NLVU University Medical Center98
已完成
4 期
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary BypassIntravascular CoagulationNCT05426031University of Miami130